Detection of relevant variants of the KRAS and the BRAF gene

Scientists of the Saarland University and the Charité Berlin established an assay which allows the selective detection of all 14 clinically relevant variants of the KRAS gene (codon 12 and 13) and the BRAF gene (codon 600-2). Compared to the most frequently used technique of direct sequencing, the assay shows a much higher sensitivity with a reliable detection limit of 5%, compared to 20% of mutated DNA in a wild type background, with causing only one third of the costs of direct sequencing, as the assay does not require complicated establishment procedures, expensive lab automation or technical replicates.

Further Information: PDF

Universität des Saarlandes Wissens- und Technologietransfer GmbH PatentVerwertungsAgentur der saarländischen Hochschulen
Phone: +49 (0)681/302-71302

Contact
Dipl.-Kfm. Axel Koch (MBA), Dr. Conny Clausen, Dr. Hauke Studier, Dr. Susanne Heiligenstein

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

Superradiant atoms could push the boundaries of how precisely time can be measured

Superradiant atoms can help us measure time more precisely than ever. In a new study, researchers from the University of Copenhagen present a new method for measuring the time interval,…

Ion thermoelectric conversion devices for near room temperature

The electrode sheet of the thermoelectric device consists of ionic hydrogel, which is sandwiched between the electrodes to form, and the Prussian blue on the electrode undergoes a redox reaction…

Zap Energy achieves 37-million-degree temperatures in a compact device

New publication reports record electron temperatures for a small-scale, sheared-flow-stabilized Z-pinch fusion device. In the nine decades since humans first produced fusion reactions, only a few fusion technologies have demonstrated…

Partners & Sponsors